This Once-a-Month Ozempic Rival Just Delivered Big Results
People taking Amgen's MariTide lost up to 20% of their body weight in a Phase II trial.
People taking Amgen's MariTide lost up to 20% of their body weight in a Phase II trial.
People taking Amgen's MariTide lost up to 20% of their body weight in a Phase II trial.
External Content
| Source | RSS or Atom Feed |
| Feed Location | http://gizmodo.com/rss |
| Feed Title | Gizmodo |
| Feed Link | https://gizmodo.com/ |
| Reply | 0 comments |